Data from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

MLA

Ignacio Gil-Bazo, et al. Data from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6518746.v1.

APA

Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, Ruben Pio, Miriam Redrado, María D. Lozano, Jackeline Agorreta, María J. Pajares, Paul A. Nguewa, & Mariano Ponz-Sarvisé. (2023). Data from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance. https://doi.org/10.1158/1078-0432.c.6518746.v1

Chicago

Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, et al. 2023. “Data from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance,” March. doi:10.1158/1078-0432.c.6518746.v1.